KR101888104B9 - MET 14 siRNA MET exon 14 skipping specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same - Google Patents

MET 14 siRNA MET exon 14 skipping specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same

Info

Publication number
KR101888104B9
KR101888104B9 KR20160132099A KR20160132099A KR101888104B9 KR 101888104 B9 KR101888104 B9 KR 101888104B9 KR 20160132099 A KR20160132099 A KR 20160132099A KR 20160132099 A KR20160132099 A KR 20160132099A KR 101888104 B9 KR101888104 B9 KR 101888104B9
Authority
KR
South Korea
Prior art keywords
met
sirna
treating
preventing
pharmaceutical composition
Prior art date
Application number
KR20160132099A
Other languages
Korean (ko)
Other versions
KR20180040343A (en
KR101888104B1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to KR1020160132099A priority Critical patent/KR101888104B1/en
Publication of KR20180040343A publication Critical patent/KR20180040343A/en
Application granted granted Critical
Publication of KR101888104B9 publication Critical patent/KR101888104B9/en
Publication of KR101888104B1 publication Critical patent/KR101888104B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020160132099A 2016-10-12 2016-10-12 MET exon 14 skipping specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same KR101888104B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160132099A KR101888104B1 (en) 2016-10-12 2016-10-12 MET exon 14 skipping specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160132099A KR101888104B1 (en) 2016-10-12 2016-10-12 MET exon 14 skipping specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same

Publications (3)

Publication Number Publication Date
KR20180040343A KR20180040343A (en) 2018-04-20
KR101888104B9 true KR101888104B9 (en) 2018-08-14
KR101888104B1 KR101888104B1 (en) 2018-08-14

Family

ID=62088474

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160132099A KR101888104B1 (en) 2016-10-12 2016-10-12 MET exon 14 skipping specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same

Country Status (1)

Country Link
KR (1) KR101888104B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015002512A1 (en) * 2013-07-05 2015-01-08 (주)바이오니아 Dengue virus-specific sirna, double helix oligo-rna structure comprising sirna, and composition for suppressing proliferation of dengue virus comprising rna structure

Also Published As

Publication number Publication date
KR20180040343A (en) 2018-04-20
KR101888104B1 (en) 2018-08-14

Similar Documents

Publication Publication Date Title
IL266674A (en) Compositions and methods for the treatment of opioid overdose
EP3498297C0 (en) Pharmaceutical composition for the treatment of autism
SG11202100076RA (en) Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
PL3416957T3 (en) 6-heterocyclyl-4-morpholin-4-ylpyridin-2-one compounds useful for the treatment of cancer and diabetes
ZA201900960B (en) Methods and compositions for the treatment of cancer
PT3416945T (en) 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
IL263793A (en) Compounds and compositions for the treatment of cancer
GB2558021B (en) Composition for treatment and/or nutrition of poultry
IL266486A (en) Pharmaceutical compositions and methods for the treatment of cancer
IL280587B (en) Flurocytidine derivatives and its composition for the treatment of cancer
HK1257584A1 (en) Medicine for preventing and treating systemic sclerosis and use of the medicine
IL275525A (en) Pharmaceutical composition for the treatment of cancer
IL272147A (en) Methods and compositions for the treatment of cancer
PL3290051T3 (en) Pharmaceutical composition for treating and/or preventing cancer
KR101913693B9 (en) SS18-SSX siRNA SS18-SSX fusion gene specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same
EP3372233A4 (en) Pharmaceutical composition for treating and/or preventing cancer
PT3236961T (en) Pharmaceutical composition for preventing or treating cancer and method using thereof
KR101888104B9 (en) MET 14 siRNA MET exon 14 skipping specific siRNA and pharmaceutical composition for preventing or treating of cancer containing the same
PL3319638T3 (en) Cineol-containing composition for the treatment of tumours and/or cancers
PT3785733T (en) Pharmaceutical composition for the treatment of autism
GB201820451D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820455D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820452D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
EP3498284A4 (en) Pharmaceutical composition for treating and/or preventing cancer
EP3437656A4 (en) Pharmaceutical composition for treating and/or preventing cancer

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Publication of correction